Skip to main content

Medtronic plc

For the period ended Apr 26, 2024. Filed Jun 20, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Jun 20, 2024

MDT$101.59-1.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 15. Exhibits and Financial Statement Schedules

(a)1. Financial Statement Schedule
Schedule II. Valuation and Qualifying Accounts — fiscal years ended April 26, 2024, April 28, 2023, and April 29, 2022.

MEDTRONIC PLC AND SUBSIDIARIES

SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS

(in millions)

Additions · Deductions
Balance atBeginning ofFiscal Year · Charges to Income · Charges to Other Accounts · Other Changes (Debit) Credit · Balanceat End ofFiscal Year
Allowance for doubtful accounts and credit losses:
Fiscal year ended April 26, 2024$176$90$—$(93)(a)$173
Fiscal year ended April 28, 202323073—(127)(a)176
Fiscal year ended April 29, 202224158—(69)(a)230
Deferred tax valuation allowance:
Fiscal year ended April 26, 2024$11,311$1,522$3(b)$(108)(c)$13,271
545(e)(2)(d)
Fiscal year ended April 28, 20236,5834,77939(b)(63)(c)11,311
1(d)(27)(e)
Fiscal year ended April 29, 20225,822884(19)(d)(103)(c)6,583

(a) Primarily consists of uncollectible accounts written off, less recoveries.

(b) Reflects the impact from acquisitions.

(c) Primarily reflects carryover attribute utilization and expiration.

(d) Primarily reflects the effects of currency fluctuations.

(e) Primarily reflects the impacts from tax rate changes.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.